We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microrheological Method Determines Blood Type

By LabMedica International staff writers
Posted on 13 Aug 2013
Print article
Image: Scheme of microfluidic apparatus for blood typing (Graphics courtesy of the Polish Institute of Physical Chemistry).
Image: Scheme of microfluidic apparatus for blood typing (Graphics courtesy of the Polish Institute of Physical Chemistry).
The development of microfluidic blood-typing assays can reduce the time of analysis, and enable simultaneous determination of the most clinically important antigens.

A method for typing and subtyping blood has been developed in a simple microfluidic system that monitors the speed of flow of microdroplets and determining agglutination in small samples of liquid.

Scientists at the Institute of Physical Chemistry of the Polish Academy of Sciences (Warsaw, Poland) have demonstrated a microfluidic method for reproducible and objective determination of agglutination in small, nanoliter quantities of liquid. They demonstrated the reliability of the method on the model example of determination of blood type, yet the method should also be possible to use with the wide range of agglutination assays used in in vitro diagnostics.

The investigators tested agglutination in droplets with A, B and O blood groups, and then a second series of agglutination test in droplets with different Rh factors. Each series was performed for both standardized red blood cells and human blood samples. The red blood cells were not removed from the whole blood before these tests. In each series a droplet with antibodies was linked in the merging chamber with a droplet containing red blood cells. The merging chamber was equipped with two electrodes connected to a source of alternating current (AC) electrostatic potential. An oscillating electric field speeds up the coalescence of droplets arriving from the individual T-junctions. A created droplet was sent to the section of measurement for the time of flow.

The method had a very high sensitivity and reliability. The reliability approached 100% with an estimated chance of mistyping on the order of one per million samples. The method of detection of agglutination could potentially be used for automating various agglutination assays. The authors noted that the method offers the potential benefits of a reduction of the volume of blood sample to single microliters for the whole test, the lack of requirement for preprocessing such as centrifugation, and eliminating any subjectivity from the procedure.

Importantly, the method could be compliant both with a point-of-care format for the simplest blood-typing protocols and with multiplexed assays for complex analyses, such as cross-match testing or other multiple antigen determinations in a bench-top format. The study was published on June 18, 2013, in the journal Lab on a Chip.

Related Links:
Polish Institute of Physical Chemistry

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
DNA Extraction Kit
Ron’s Gel Extraction Mini Kit
New
Refrigerated Centrifuge
CAPPRondo Refrigerated Centrifuge

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.